Communiqués Orthofix Medical Inc.

Actions

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 07/06/2024			Varia. 5j.	Varia. 1 janv.
13,42 ^USD	-0,89 %		-2,26 %	-0,45 %

23/05	Orthofix Medical Inc. nomme Max Reinhardt au poste de président de la division Global Spine à compter du 10 juin 2024	CI
09/05	Orthofix Medical Inc. annonce l'autorisation 510(K) de la FDA pour le clou télescopique Rodeo	CI

Orthofix Names Max Reinhardt President of Global Spine Business	23/05	BU
Orthofix Medical Wins 'Best Patient Experience Solution' Award in 2024 MedTech Breakthrough Awards Program	17/05	AQ
Orthofix Wins “Best Patient Experience Solution” Award in 2024 MedTech Breakthrough Awards Program	16/05	BU
Orthofix Announces FDA 510(k) Clearance for the Rodeo Telescopic Nail	09/05	BU
Orthofix Medical : OFIX May 2024 Investor Deck	07/05	PU
Orthofix: Q1 Earnings Snapshot	07/05	AQ
Orthofix Reports First Quarter 2024 Results	07/05	BU
Orthofix Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024	23/04	BU
Orthofix Names Andres Cedron as New Chief Legal Officer	16/04	BU
Lucas Vitale Joins Orthofix as Chief People and Business Operations Officer	18/03	BU
Orthofix Medical : OFIX March 2024 Investor Deck	18/03	PU
Orthofix: Q4 Earnings Snapshot	05/03	AQ
Orthofix Medical : OFIX March 2024 Investor Deck	05/03	PU
Orthofix Medical : March 2024 Proforma Non GAAP Financials	05/03	PU
Orthofix Reports Fourth Quarter and Full Year 2023 Results	05/03	BU
Orthofix Medical Announces New President for Bone Growth Therapies Business	01/03	AQ
Orthofix Announces New President for Bone Growth Therapies Business	29/02	BU
Orthofix Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for March 5, 2024	21/02	BU
Orthofix Announces Commercial Partnership with MRIguidance	18/01	BU
Julie Andrews Begins as New Chief Financial Officer at Orthofix	16/01	BU

Aucun résultat pour cette recherche